CUTX-101 Shows Promise for Menkes Disease
https://pixabay.com/en/copper-scrap-metal-scrap-disposal-1504098/

CUTX-101 Shows Promise for Menkes Disease

Recently, biopharmaceutical company Fortress Biotech announced positive clinical results for CUTX-101 (copper histidinate). The data highlights the efficacy of CUTX-101 for patients with Menkes disease. As there are currently no…

Continue Reading CUTX-101 Shows Promise for Menkes Disease
New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease
source: pixabay.com

New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease

  In a recent press release, biopharmaceutical company Fortress Biotech announced that their study regarding ATP7A targeted next generation DNA sequencing for Menkes disease was published in Molecular Genetics and Metabolism…

Continue Reading New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease